Open AccessThe Correlation Between Three-Dimensional Ultrasound Measurement of Fetal Adrenal Gland and Maternal Serum Fructosamine Level in Gestational Diabetes Mellitus: Prospective Cohort Study
Author(s) -
Saowapak Junhasavasdikul,
Panyu Panburana,
Sommart Bumrungphuet,
Wirada Dulyaphat
Publication year - 2022
Publication title -
international journal of women's health
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.136
H-Index - 45
ISSN - 1179-1411
DOI - 10.2147/ijwh.s373087
Subject(s) - medicine , fructosamine , fetus , adrenal gland , gestation , gestational diabetes , gestational age , obstetrics , ultrasound , birth weight , pregnancy , prospective cohort study , population , diabetes mellitus , endocrinology , radiology , biology , environmental health , genetics
Gestational diabetes mellitus (GDM) has an impact on fetal adrenal gland size and volume, which are greater in the GDM population. This study used 2D and 3D ultrasound scanning to determine the correlation of fetal adrenal gland size and volume with fructosamine levels, HbA1c levels, estimated fetal weight (EFW), and neonatal birth weight in GDM patients.